Prescription Drugs and Wellness Programs in 2026 and 2027
Part D Out-of-Pocket Reductions and Premium Shifts
Under the Inflation Reduction Act redesign, annual out-of-pocket Part D spending is capped at $2,100 in 2026 across all formulary medications.
This out-of-pocket maximum is finalized at $2,400 in 2027. The protection applies whether you use a standalone Part D plan or an integrated Medicare Advantage plan.
The maximum standard Part D deductible is $615 in 2026, rising to $700 in 2027. Some plans waive or reduce this deductible for common generic drugs.
Medicare also offers the Medicare Prescription Payment Plan, a voluntary program spreading drug cost-sharing into monthly payments throughout the calendar year.
Despite lower spending caps, standalone Part D premiums face significant upward pressure after the federal government ended the temporary Part D Premium Stabilization Demonstration after 2026.
Consequently, roughly 1.2 million standalone Part D enrollees face plan terminations at year-end. Beneficiaries who stay in remaining standalone plans face an average 50% premium jump in 2027, rising from $34 to $51 monthly unless they switch.
Federal price negotiations also lower prescription prices directly. Negotiated prices for the first 10 selected Part D drugs took effect in 2026, while 15 additional drugs—including GLP-1 medications like Ozempic—take effect on January 1, 2027.
New Lifestyle and Wellness Initiatives for 2027
The 2027 Medicare & You guidelines introduce key models expanding preventive care and chronic disease management, providing targeted support for common diagnoses.
The new ACCESS Model supports Original Medicare beneficiaries living with chronic conditions like diabetes, high blood pressure, or depression. It covers lifestyle coaching, wearable monitoring devices, and virtual clinical visits at little or no cost.
Another addition is the Medicare GLP-1 Bridge program. This pathway allows qualifying Part D enrollees to obtain specific glucagon-like peptide-1 (GLP-1) medications for weight loss and health improvement for a flat $50 monthly copay.
